TrialPloS one2016

An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.

Josep M Llibre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.